Keywords: strong, data, avastin, may, lead, lower, dose

Strong data for Avastin may lead to lower dose

Article | 05 March 2007

Print This

Swiss drug major Roche says that a Phase III study investigating its drug Avastin (bevacizumab) in combination with chemotherapy met ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in